DGDavid Gyllenberg

David Gyllenberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David Gyllenberg has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Andre Sourander

    Research Centre for Child Psychiatry, University of Turku, Turku, Finland

    6 shared publications
  • Andre Sourander

    Affiliation Department of Child Psychiatry and INVEST Research Flagship Center, University of Turku and Turku University Hospital, Turku, Finland

    3 shared publications
  • Alan S. Brown

    Department of Psychiatry, College of Physicians and Surgeons of Columbia University and New York State Psychiatric Institute, New York, New York, USA

    2 shared publications
  • Antti Kääriälä

    Finnish Institute of Health and Welfare Helsinki Finland

    2 shared publications
  • Ian W. McKeague

    Department of Biostatistics, Columbia University Mailman School of Public Health, New York, New York, USA

    2 shared publications
  • Ida Ringbom

    Department of Adolescent Psychiatry, Helsinki University Hospital, Helsinki, Finland

    2 shared publications

Latest Publications

  • Open Access

    Systematic review: Efficacy of off-label antipsychotic use in children and adolescents with obsessive-compulsive, mood dysregulation, depression, anxiety, and sleep-related disorders

    by Akseli K. Holopainen, Pyry A. Vainiotalo, Bianca P. Arrhenius, Ida Ringbom, Mirja Laurila, David Gyllenberg

    Antipsychotics (APs) are not officially approved for the treatment of depressive, anxiety, obsessive-compulsive, emotional dysregulation, or sleep disorders among children and adolescents. Despite this, the treatment of these common and comorbid disorders is likely to partially explain the increased AP use. We assessed all studies reporting changes in symptoms or functioning during antipsychotic treatment for these diagnoses among patients < 18 years old. We systematically searched MEDLINE, EBM reviews and PsycINFO databases for all studies published by October 30, 2025, reporting on the effectiveness of APs for obsessive-compulsive, mood dysregulation, depression, anxiety, and sleep-related disorders among patients < 18 years. We evaluated evidence using the Grading of Recommendations Assessment, Development and Evaluation approach (GRADE). Of the 2237 identified studies, 119 were eligible for full-text review, and 13 were included in the final review. One study compared two antipsychotics, while the rest were uncontrolled open-label studies, case series, or case reports. No randomized controlled trials nor studies on sleep or anxiety disorders were identified. While there were reported changes in standardized mean scores between baseline and endpoint, the level of evidence in obsessive-compulsive, mood dysregulation, and depression related disorders was very low. The identified very low level of evidence stands in stark contrast to clinical practice, where APs are increasingly prescribed. Future methodologically robust studies are needed to demonstrate efficacy. Given the side effects of APs, physicians should carefully consider the benefits and harms when prescribing them for off-label indications.

  • Open Access

    Selective serotonin reuptake inhibitor use during pregnancy and maternal depression—a nationwide birth cohort study on risks to the mother and the newborn

    by Heli Malm, Alan S. Brown, Keely Cheslack-Postava, Mika Gissler, David Gyllenberg, Emmi Heinonen, Susanna Hinkka-Yli-Salomäki, Ian W. McKeague, Aleksi Tornio, Subina Upadhyaya, et al.


  • Open Access

    Comparison of new psychiatric diagnoses among Finnish children and adolescents before and during the COVID-19 pandemic: A nationwide register-based study

    by David Gyllenberg, Kalpana Bastola, Wan Mohd Azam Wan Mohd Yunus, Kaisa Mishina, Emmi Liukko, Antti Kääriälä, Andre Sourander

    Background: Coronavirus Disease 2019 (COVID-19) restrictions decreased the use of specialist psychiatric services for children and adolescents in spring 2020. However, little is known about the pattern once restrictions eased. We compared new psychiatric diagnoses by specialist services during pandemic and pre-pandemic periods. Methods and findings: This national register study focused on all Finnish residents aged 0 to 17 years from January 2017 to September 2021 (approximately 1 million a year). The outcomes were new monthly diagnoses for psychiatric or neurodevelopmental disorders in specialist services. These were analyzed by sex, age, home location, and diagnostic groups. The numbers of new diagnoses from March 2020 were compared to predictive models based on previous years. The predicted and observed levels in March to May 2020 showed no significant differences, but the overall difference was 18.5% (95% confidence interval 12.0 to 25.9) higher than predicted in June 2020 to September 2021, with 3,821 more patients diagnosed than anticipated. During this period, the largest increases were among females (33.4%, 23.4 to 45.2), adolescents (34.4%, 25.0 to 45.3), and those living in areas with the highest COVID-19 morbidity (29.9%, 21.2 to 39.8). The largest increases by diagnostic groups were found for eating disorders (27.4%, 8.0 to 55.3), depression and anxiety (21.0%, 12.1 to 51.9), and neurodevelopmental disorders (9.6%, 3.0 to 17.0), but psychotic and bipolar disorders and conduct and oppositional disorders showed no significant differences and self-harm (−28.6, −41.5 to −8.2) and substance use disorders (−15.5, −26.4 to −0.7) decreased in this period. The main limitation is that data from specialist services do not allow to draw conclusions about those not seeking help. Conclusions: Following the first pandemic phase, new psychiatric diagnoses in children and adolescents increased by nearly a fifth in Finnish specialist services. Possible explanations to our findings include changes in help-seeking, referrals and psychiatric problems, and delayed service access.


  • Open Access

    School performance and later diagnoses of nonaffective psychoses, bipolar disorder, and depression

    by David Gyllenberg, Tiina Ristikari, Ian Kelleher, Antti Kääriälä, Mika Gissler

    Objective: It is unclear whether there are differences between specific school subject performance and later psychiatric disorders. We examined whether mean grade point average (MGPA) and specific school subjects associated with diagnoses of nonaffective psychoses, bipolar disorder and depression.Methods: In this register‐based study, we studied the Finnish population born in 1987 who had available MGPA and six specific school grades (age = 15.4–16.4 years; n = 50,508). Grades were analyzed with smoothing splines. Covariates included sex, urbanicity, parental education level and parental diagnosed psychiatric disorders. Outcomes were incident nonaffective psychosis, bipolar disorder and depression diagnosed in specialized services until year 2015 (age = 28.0–28.9 years).Results: During the follow‐up, 727 individuals were diagnosed with nonaffective psychoses, 489 with bipolar disorder and 3492 with depression. MGPA was inversely associated with all outcomes. In multivariate models including specific school subjects and covariates, the school subject with largest risk ratios (RR) was Physical Education (RR and Bonferroni‐corrected confidence interval [CI] at −1.5 SD: nonaffective psychoses 1.63, 1.36–1.95; bipolar disorder 1.64, 1.30–2.05; depression 1.72, 1.53–1.93). Higher grades in Art were associated with nonaffective psychoses and depression (RR and Bonferroni‐corrected CI at +1.5 SD: nonaffective psychoses 1.48, 1.11–1.96; depression 1.22, 1.07–1.38).Conclusion: There was a robust association between poorer scores on Physical Education and risk for psychosis, bipolar disorder and depression. Higher grades in Art were also associated with risk for later disorders. Subject specific school performance may be more informative about mental disorder risk than overall school performance.


  • Open Access

    Registered psychiatric service use, self-harm and suicides of children and young people aged 0–24 before and during the COVID-19 pandemic: a systematic review

    by Wan Mohd Azam Wan Mohd Yunus, Laura Kauhanen, Andre Sourander, June S. L. Brown, Kirsi Peltonen, Kaisa Mishina, Lotta Lempinen, Kalpana Bastola, Sonja Gilbert, David Gyllenberg

    Background: The COVID-19 pandemic has impacted on psychiatric symptoms of children and young people, but many psychiatric services have been disrupted. It is unclear how service use, self-harm and suicide has changed since the pandemic started. To gain timely information, this systematic review focused on studies based on administrative data that compared psychiatric service use, self-harm and suicide before and during the pandemic among children and young people.Methods and finding: A systematic review of studies published in English from 1 January 2020 to 22 March 2021 was conducted, using the Web of Science, PubMed, Embase and PsycINFO databases. Increases or reductions in service use were calculated and compared using percentages. Of the 2,676 papers retrieved, 18 were eligible for the review and they provided data from 19 countries and regions. Most studies assessed changes during the early phase of the COVID-19 pandemic, from March to July 2020, and three assessed the changes until October 2020. Fifteen studies reported a total of 21 service use outcomes that were quantitively examined. More than three-quarters of the 21 outcomes (81%) fell by 5–80% (mean reduction = 27.9%, SD = 35%). Ten of the 20 outcomes for psychiatric emergency department (ED) services reduced by 5% to 80% (mean = 40.1%, SD = 34.9%) during the pandemic. Reductions in service use were also recorded for ED visits due to suicide ideation and self-harm, referrals to secondary mental health services, psychiatric inpatient unit admissions and patients receiving treatment for eating disorders. However, there were also some increases. Suicide rate and the number of ED visits due to suicide attempts have increased, and there was an increase in the number of treatment sessions in a service that provided telemedicine.Conclusion: Most of the studies showed reductions in the use of psychiatric services by children and young people during the early phase of the pandemic and this highlighted potential delays or unmet needs. Suicide rate has increased during the second wave of the pandemic. Further studies are needed to assess the pattern of service use in the later phases of the COVID-19 pandemic.


  • Open Access

    Time trends in treated incidence, sociodemographic risk factors and comorbidities: a Finnish nationwide study on anxiety disorders

    by Prakash Khanal, Tiia Ståhlberg, Terhi Luntamo, David Gyllenberg, Kim Kronström, Auli Suominen, Andre Sourander

    Background: There has been a lack of research about the time trends and socio-demographic risk factors for children and adolescents who receive treatment for anxiety disorders. This study aimed to fill these gaps in our knowledge by examining a nationwide sample of Finnish children and adolescents diagnosed in specialized healthcare settings. Methods: This study comprised national register data of all singleton children born in Finland from 1992–2006 who were diagnosed with anxiety disorders from 1998–2012. The changes in time trends in incidence were studied by dividing the study sample into three cohorts by birth years: 1992–1996, 1997–2001 and 2002–2006, who were followed up until the age of 20, 15 and 10 years, respectively. The 22,388 individuals with anxiety disorders were age and gender matched with 76,139 controls from the general population. Logistic regression was used to examine the socio-demographic risk factors and anxiety disorders in the entire sample. Comorbid disorders were examined in the oldest birth cohort (1992–1996 born). Results: Comparing the 1992–1996 and 2002–2006 cohorts showed that the cumulative incidence of treated anxiety disorders at the age of 10 increased from 0.3 to 1.2% among females and 0.46 to 1.9% among males. Subjects had higher likelihood for being diagnosed with an anxiety disorder if their mothers had low maternal socio-economic status class at birth (OR 1.53, 95% CI 1.45–1.61) compared to higher SES class, and marital status was single at the time of birth (OR 2.02, 95% CI 1.87–2.17) compared to married or in a relationship. They had lower risk of anxiety disorders diagnosis if born in rural (OR 0.82, 95% CI 0.79–0.86) or semi-urban areas (OR 0.79, 95% CI 0.76–0.82) when compared to urban residence. There was a wide range of psychiatric comorbidities, and unipolar depression was the most common (31.2%). Conclusion: Anxiety disorders diagnosed by specialized Finnish services increased from 1998–2012 in both genders. This could indicate a real increase in overall anxiety disorders or an increase in treatment seeking. The findings on maternal socioeconomic status and single parenting improve the recognition of the environmental risk factors for anxiety disorders among children and adolescents.


  • Psychiatric disorders diagnosed in adolescence and subsequent long-term exclusion from education, employment or training: longitudinal national birth cohort study

    by Ida Ringbom, Jaana Suvisaari, Antti Kääriälä, Andre Sourander, Mika Gissler, Tiina Ristikari, David Gyllenberg

    Background: Long-term ‘not in education, employment or training’ (NEET) status is an important indicator of youth marginalisation.Aims: To carry out a comprehensive overview of the associations between different psychiatric illnesses and long-term NEET status.Method: We used the register-based 1987 Finnish Birth Cohort study, which includes all live births in Finland during that year. The analyses comprised 55 273 individuals after exclusions for intellectual disability, death or emigration. We predicted that psychiatric disorders, diagnosed by specialist services between 1998 and 2007 when the cohort were 10–20 years of age, would be associated with subsequent long-term NEET (defined as NEET for at least 5 years between 2008 and 2015, when they were 20–28 years of age).Results: In total, 1438 individuals (2.6%) were long-term NEET during follow-up and the associations between long-term NEET and the 11 diagnostic categories we studied were statistically significant (P < 0.001). In multivariate models we included sociodemographic characteristics and upper secondary education as covariates, and the highest effect sizes, measured by odds ratios (OR) with 95% confidence intervals (CI), were found for psychosis (OR = 12.0, 95% CI 9.5–15.2) and autism spectrum disorder (OR = 17.3, 95% CI 11.5–26.0). If individuals had not successfully completed this education, 70.6% of those with autism spectrum disorder and 48.4% of those with psychosis were later long-term NEET.Conclusions: Adolescents who receive treatment for psychiatric disorders, particularly autism spectrum disorder or psychosis, need support to access education and employment. This could help to prevent marginalisation in early adulthood.


  • Open Access

    Robust data‐driven identification of risk factors and their interactions: A simulation and a study of parental and demographic risk factors for schizophrenia

    by David Gyllenberg, Ian W. McKeague, Andre Sourander, Alan S. Brown

    Objectives: Few interactions between risk factors for schizophrenia have been replicated, but fitting all such interactions is difficult due to high‐dimensionality. Our aims are to examine significant main and interaction effects for schizophrenia and the performance of our approach using simulated data.Methods: We apply the machine learning technique elastic net to a high‐dimensional logistic regression model to produce a sparse set of predictors, and then assess the significance of odds ratios (OR) with Bonferroni‐corrected p‐values and confidence intervals (CI). We introduce a simulation model that resembles a Finnish nested case–control study of schizophrenia which uses national registers to identify cases (n = 1,468) and controls (n = 2,975). The predictors include nine sociodemographic factors and all interactions (31 predictors).Results: In the simulation, interactions with OR = 3 and prevalence = 4% were identified with p < .001), urbanicity (1.3, 1.1–1.7; p = .001), and paternal age ≥35 (1.3, 1.004–1.6; p = .04) were significant.Conclusions: We have provided an analytic pipeline for data‐driven identification of main and interaction effects in case–control data. We identified highly replicated main effects for schizophrenia, but no interactions.


  • Hypothyroxinemia During Gestation and Offspring Schizophrenia in a National Birth Cohort

    by David Gyllenberg, Andre Sourander, Heljä-Marja Surcel, Susanna Hinkka-Yli-Salomäki, Ian W. McKeague, Alan S. Brown